Summary Stage 2018: Fallopian Tube
Summary Stage 2018
Notes
**Fallopian Tube**
8000-8700, 8720-8790, 8806, 8810, 8815, 8822, 8825, 8890, 8930-8931, 8933, 8935-8936, 8950, 8960, 8980, 9000, 9050, 9052, 9060, 9070-9071, 9073, 9080, 9085, 9090-9091, 9100, 9110, 9700-9701
C570
C570 Fallopian tube
**Note 1:** The following sources were used in the development of this chapter
* SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf)
* SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/)
* Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx
* Chapter 55 *Ovary, Fallopian Tube, and Primary Peritoneal Carcinoma*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois.
**Note 2:** See the following schemas for the listed histologies
* 8710-8714, 8800-8805, 8811-8814, 8820-8821, 8823-8824, 8826-8881, 8891-8921, 8932, 8934, 8940-8941, 8951-8959, 8963-8975, 8981-8991, 9010-9045, 9051, 9053-9055, 9061-9065, 9072, 9081-9084, 9086, 9101-9105, 9120-9137, 9141-9582: *Soft Tissue*
* 9140: *Kaposi Sarcoma*
**Note 3:** Ascites, NOS is considered negative.
**Note 4:** Peritoneal implants outside the pelvis must be microscopically confirmed. Peritoneal implants may also be called seeding, salting, talcum powder appearance, or studding.
**Note 5:** If implants are mentioned, determine whether they are in the pelvis or in the abdomen and code appropriately to regional by direct extension or to distant. If not stated, code to distant.
| SS2018 |
Description |
| 0 |
In situ: noninvasive, intraepithelial
- Limited to tubal mucosa
- Preinvasive |
| 1 |
Localized only (localized, NOS)
- FIGO Stage IA
+ Limited to one fallopian tube
- FIGO Stage IB
+ Limited to both fallopian tubes
- FIGO Stage IC1
+ Limited to both fallopian tubes WITH surgical spill
- FIGO Stage IC [NOS] (does not include IC2, IC3)
+ Limited to one or both fallopian tube(s), NOS
- FIGO Stage I [NOS] |
| 2 |
Regional by direct extension only
- FIGO Stage IC2
+ Limited to one or both fallopian tubes
* WITH capsule ruptured before surgery
* OR tumor on fallopian tube surface
- FIGO Stage IC3
+ Malignant cells in ascites or peritoneal washings
* WITH or WITHOUT capsule rupture
- FIGO Stage IIA
+ Extension to or implants on
* Adnexa
* Corpus uteri
* Ovary(ies)
* Uterus, NOS
- FIGO Stage IIB
+ Extension to or implants to other pelvic tissues
* Adjacent peritoneum
* Broad ligament, ipsilateral
* Cul de sac (rectouterine pouch)
* Mesosalpinx, ipsilateral
* Rectosigmoid
* Sigmoid
- FIGO Stage II [NOS]
+ Confined to pelvis
+ Tumor involves one or both fallopian tubes
* WITH pelvic extension, NOS (below pelvic brim)
- FIGO Stage IIIA
+ Microscopic peritoneal implants beyond pelvis
* Includes peritoneal surface/capsule of liver
* Omentum
* Small intestine |
| 3 |
Regional lymph node(s) involved only
- Aortic, NOS
+ Lateral (lumbar)
+ Para-aortic
+ Periaortic
- Iliac, NOS
+ Common
+ External
+ Internal (hypogastric, obturator, NOS)
- Intra-abdominal
- Lateral sacral (laterosacral)
- Pelvic, NOS
- Retroperitoneal, NOS
- Subdiaphragmatic (primary peritoneal carcinoma)
- Regional lymph node(s), NOS
+ Lymph node(s), NOS |
| 4 |
Regional by BOTH direct extension AND regional lymph node(s) involved
- Codes (2) + (3) |
| 7 |
Distant site(s)/lymph node(s) involved
- Distant site(s) (including further contiguous extension)
+ FIGO Stage IIIB
* Includes peritoneal surface of liver
* Macroscopic peritoneal implants beyond pelvis less than or equal to 2 cm in diameter
+ FIGO Stage IIIC
* Includes peritoneal surface of liver (liver capsule)
* Includes tumor extension to liver and spleen WITHOUT parenchymal
* Involvement of either organ
* Macroscopic peritoneal implants beyond pelvis greater than 2 cm in diameter
+ FIGO Stage III [NOS]
* One or both fallopian tubes involved WITH microscopic confirmed peritoneal metastasis
outside of the pelvis
* Peritoneal implants, NOS
+ FIGO Stage IVA
* Pleural effusion with positive cytology
+ FIGO Stage IVB
* Extra-abdominal organs
* Liver parenchymal
* Spleen parenchymal
* Transmural involvement of intestine
+ FIGO Stage IV [NOS]
- Distant lymph node(s), NOS
+ Inguinal
- Distant metastasis, NOS
+ Carcinomatosis (involvement of multiple parenchymal organs)
* WITH or WITHOUT distant lymph node(s) OR pleural effusion
+ Distant metastasis WITH or WITHOUT distant lymph node(s) |
| 9 |
Unknown if extension or metastasis |
(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998
(2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.
(3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL)
(4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 3-30
(5) **Introduction to Female Reproductive Organs**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 631
(6) Prat, J., Olawaiye, A.B., Mutch, D.G., et al. **Ovary, Fallopian Tube, and Primary Peritoneal Carcinoma**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 681-690
